Browse 24950 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
March 31st, 2021 |
Infectious Etiology of Alzheimer's Disease (R01 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2024 |
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R33 Clinical Trial Required) |
National Institutes of Health |
January 13th, 2024 |
NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) |
National Institutes of Health |
January 13th, 2024 |
NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required) |
National Institutes of Health |
March 12th, 2021 |
HIV/TB Agency, Information, and Services Activity (HIV/TB AIS) |
Burma USAID Rangoon |
March 8th, 2021 |
USAID Improved Family Planning Initiative |
Mozambique USAID Maputo |
January 7th, 2024 |
NIDCR Dual Degree Dentist Scientist Predoctoral to Postdoctoral Transition Award (F99/K00 Independent Clinical Trial Not Allowed) |
National Institutes of Health |
January 12th, 2022 |
Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required) |
National Institutes of Health |
May 29th, 2021 |
National Paralysis Resource Center |
Administration for Community Living |
April 12th, 2021 |
Autism Secondary Data Analysis Research Program |
Health Resources and Services Administration |
May 7th, 2024 |
Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional) |
National Institutes of Health |
November 3rd, 2021 |
Biomarkers for Diabetic Foot Ulcers through the Diabetic Foot Consortium (R61/R33 Clinical Trial Not Allowed) |
National Institutes of Health |
June 18th, 2021 |
Immune Development in Early Life (IDEaL) (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
May 17th, 2021 |
Drug-Free Communities (DFC) Support Program |
Centers for Disease Control NCIPC |
May 3rd, 2021 |
Collecting Violent Death Information Using the National Violent Death Reporting System (NVDRS) |
Centers for Disease Control NCIPC |
May 4th, 2021 |
Technical Assistance (TA) to Support the Health Information Systems (HIS) of the South African Government to Improve Patient-level Data Systems at the National and Sub-National Departments of Health (DoH) under PEPFAR |
Centers for Disease Control CGH |
June 18th, 2021 |
Immune Development in Early Life (IDEaL) (U19 Clinical Trial Not Allowed) |
National Institutes of Health |
September 30th, 2021 |
Military Health System Research (MHSR) |
Defense Health Agency |
January 7th, 2024 |
Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of the NIDDK (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
May 26th, 2021 |
Drug-Free Communities (DFC) Support Program - Competing Continuation |
Centers for Disease Control NCIPC |
|
March 26th, 2021 |
HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required) |
National Institutes of Health |
March 26th, 2021 |
HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Coordination and Dissemination Center (R24 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2024 |
Early Stage Investigator Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
March 31st, 2021 |
HEAL Initiative: HEALthy Brain and Child Development Data Coordinating Center (U24) |
National Institutes of Health |
March 31st, 2021 |
HEAL Initiative: HEALthy Brain and Child Development Consortium Administrative Core (U24 - Clinical Trial Not Allowed) |
National Institutes of Health |
March 30th, 2021 |
HEAL Initiative: Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial - Clinical Sites (UG1 Clinical Trial Required) |
National Institutes of Health |
March 18th, 2021 |
HEAL Initiative: Optimizing Multi-Component Service Delivery Interventions for People with Opioid Use Disorder, Co-Occurring Conditions, and/or Suicide Risk (R01 Clinical Trials Optional) |
National Institutes of Health |
March 31st, 2021 |
HEAL Initiative: HEALthy Brain and Child Development Study (U01 - Clinical Trial Not Allowed) |
National Institutes of Health |
March 31st, 2021 |
HEAL Initiative: HEALthy Brain and Child Development Study (Collaborative U01- Clinical Trial Not Allowed) |
National Institutes of Health |
March 30th, 2021 |
HEAL Initiative: Data Coordinating Center for the Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial (U24 Clinical Trial Required) |
National Institutes of Health |
September 15th, 2021 |
Comprehensive HIV/AIDS Service Delivery Programs in Haiti under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
April 20th, 2021 |
Advancing Health Literacy to Enhance Equitable Community Responses to COVID-19 |
Office of the Assistant Secretary for Health |
January 7th, 2024 |
Limited Competition: Specific Pathogen Free Macaque Colonies (U42 Clinical Trial Not Allowed) |
National Institutes of Health |
January 7th, 2024 |
Priority HIV/AIDS Research within the Mission of the NIDDK (R01 Clinical Trial Optional) |
National Institutes of Health |
March 18th, 2021 |
Regulation of Brain Regional and Cell Type Specific Proteome Dynamics in Aging and Alzheimer's Disease (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
February 22nd, 2021 |
National Child Traumatic Stress Initiative - Category II, Treatment and Service Adaptation (TSA) Centers |
Substance Abuse and Mental Health Services Adminis |
March 22nd, 2021 |
Cellular Senescence Network: Consortium Organization and Data Coordinating Center (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
March 22nd, 2021 |
Cellular Senescence Network: Technology Development and Application (UG3/UH3 Clinical Trial Not Allowed) |
National Institutes of Health |
March 22nd, 2021 |
Cellular Senescence Network: Tissue Mapping Centers (U54 Clinical Trial Not Allowed) |
National Institutes of Health |
January 19th, 2021 |
Partnering with Professional and Medical Associations to Increase Vaccination Coverage Across Different Racial and Ethnic Adult Populations Experiencing Disparities |
Centers for Disease Control NCIRD |